Figure 5

Forest plot of radiological outcomes change from baseline (a) MRI T2-weighted lesions volume at the end of treatment, (b) MRI T2-weighted lesions number at 12 months, (c) number of GELs at the end of treatment. *the study used immunosuppression before AHSCT.